Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
Riociguat – Cardiology MCQ
No Comments | May 16, 2015 -
Carcinoid syndrome – Cardiology MCQ
No Comments | Apr 19, 2014 -
Radiation associated heart disease – Cardiology MCQ
No Comments | Jul 23, 2013 -
ECG Quiz 14
No Comments | Sep 8, 2017
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal